Skip to the page

Data / Drug companies / Strides Pharma Inc

Strides Pharma Inc: 12 products in the FDA NDC directory, labeler code 59556

Strides Pharma Inc (labeler code 59556) lists 12 products in the FDA National Drug Code Directory, covering 5 finished drugs by generic name. By type: 12 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on November 16, 2022.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
59556
Products in commercial distribution
12
Packages
45
Finished drugs by generic name
5
Prescription products
0
Over the counter products
12
Flagged as original packager
12 of 12 products that carry the flag
Started marketing in the last 12 months
0
Earliest marketing start
July 21, 2017
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)12100%

Products by type

TypeProductsShare
Over the counter drugs12100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Ibuprofen6190
Loratadine2125
Levonorgestrel tablet, 1.5 mg21
Cetirizine hydrochloride1119
Loperamide hydrochloride182

Dosage forms

Dosage formProductsShare
Capsule, liquid filled433.3%
Tablet, coated433.3%
Tablet325%
Tablet, orally disintegrating18.3%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Ibuprofen59556-895Capsule, liquid filledGeneric drugs (ANDA)November 16, 2022
Ibuprofen59556-764Capsule, liquid filledGeneric drugs (ANDA)November 16, 2022
Optionelle59556-286TabletGeneric drugs (ANDA)September 15, 2022
Levonorgestrel Tablet, 1.5 mg59556-282TabletGeneric drugs (ANDA)September 13, 2022
IBUPROFEN Immediate Release59556-858Tablet, coatedGeneric drugs (ANDA)March 18, 2022
IBUPROFEN Immediate Release59556-857Tablet, coatedGeneric drugs (ANDA)March 18, 2022
Ibuprofen Immediate Release59556-856Tablet, coatedGeneric drugs (ANDA)March 18, 2022
Ibuprofen Immediate Release59556-855Tablet, coatedGeneric drugs (ANDA)March 18, 2022
Loperamide Hydrochloride59556-959Capsule, liquid filledGeneric drugs (ANDA)October 22, 2021
Loratadine59556-917Tablet, orally disintegratingGeneric drugs (ANDA)August 10, 2021
Loratadine59556-301TabletGeneric drugs (ANDA)August 10, 2021
Cetirizine hydrochloride59556-894Capsule, liquid filledGeneric drugs (ANDA)July 21, 2017

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.